Beam Therapeutics (BEAM) Current Deferred Revenue (2020 - 2026)
Beam Therapeutics' Current Deferred Revenue came in at $304,000 for Q1 2026, down 99.6% from $85.2 million a year earlier and down 95.4% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Beam Therapeutics' Current Deferred Revenue was $6.66 million, down 93.9% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of 208.1% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $108.86 million in FY2024 (+58.4%), $68.71 million in FY2023 (-49.5%), $135.97 million in FY2022 (+57.6%) and $86.27 million in FY2021.
- The Q1 2026 figure represents the lowest quarterly Current Deferred Revenue since Q4 2020.
- Year-over-year, Current Deferred Revenue increased in four of the last eight quarters, with an average decline of 18.7%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q4 2024 (growth of 58.4%), and the weakest in Q1 2026 (a decline of 99.6%).
- Business Quant data shows BEAM's Current Deferred Revenue at $6.66 million (Q4 2025), $110.32 million (Q3 2025) and $105.82 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 6.66 Mn |
| Sep 30, 2025 | 110.32 Mn |
| Jun 30, 2025 | 105.82 Mn |
| Mar 31, 2025 | 85.20 Mn |
| Dec 31, 2024 | 108.86 Mn |
| Sep 30, 2024 | 89.33 Mn |
| Jun 30, 2024 | 84.93 Mn |
| Mar 31, 2024 | 72.11 Mn |
| Dec 31, 2023 | 68.71 Mn |
| Sep 30, 2023 | 153.48 Mn |
| Jun 30, 2023 | 139.13 Mn |
| Mar 31, 2023 | 142.74 Mn |
| Dec 31, 2022 | 135.97 Mn |
| Sep 30, 2022 | 159.90 Mn |
| Jun 30, 2022 | 139.67 Mn |
| Mar 31, 2022 | 115.05 Mn |
| Dec 31, 2021 | 86.27 Mn |
| Sep 30, 2021 | 12.82 Mn |
| Jun 30, 2021 | 10.02 Mn |
API Access
Beam Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();